Tatton Consulting supported Birmingham-based pharmaceutical formulation company Mesox in its successful application to Flexible, agile, scalable medicine manufacturing, awarded £363,925 by Innovate UK for the project A model-based scalable and cost-effective process platform to facilitate the manufacture of complex long-acting injectable (LAI) microspheres. The total Innovate UK grant across all project partners was £542,014.
About the funded R&D project
Long-acting injectables can transform treatment adherence, and most research has gone into new active ingredients rather than into how these products are manufactured. Release profile turns out to be sensitive to manufacturing process, so a formulation that works in the lab can behave differently at production scale. This project develops a model-based process platform to make that relationship predictable.
Award details
- Grant to Mesox: £363,925
- Total project grant (all partners): £542,014
- Competition: Flexible, agile, scalable medicine manufacturing
- Competition year: 2023/24
- Project: A model-based scalable and cost-effective process platform to facilitate the manufacture of complex long-acting injectable (LAI) microspheres
- Sector: Pharmaceutical manufacturing
- Independent verification: Innovate UK funded projects transparency dataset (UKRI), published 10 August 2026
Tatton Consulting supported the competitive grant application. The award value, competition and project title are taken from Innovate UK’s published record of funded projects.
See all Innovate UK awards Tatton Consulting has supported on our grant successes page.
